MediciNova, Inc. (MNOV)
1.46
+0.01
(+0.69%)
USD |
NASDAQ |
Nov 06, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 20:00
MediciNova Max Drawdown (5Y) : 90.32% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 90.32% |
| September 30, 2026 | 90.32% |
| August 31, 2026 | 90.32% |
| July 31, 2026 | 90.32% |
| June 30, 2026 | 90.32% |
| May 31, 2026 | 90.32% |
| April 30, 2026 | 90.32% |
| March 31, 2026 | 90.32% |
| February 28, 2026 | 90.32% |
| January 31, 2026 | 90.32% |
| December 31, 2025 | 90.32% |
| November 30, 2025 | 90.32% |
| October 31, 2025 | 90.32% |
| September 30, 2025 | 90.32% |
| August 31, 2025 | 90.32% |
| July 31, 2025 | 90.32% |
| June 30, 2025 | 90.32% |
| May 31, 2025 | 90.32% |
| April 30, 2025 | 90.32% |
| March 31, 2025 | 90.32% |
| February 28, 2025 | 90.32% |
| January 31, 2025 | 90.32% |
| December 31, 2024 | 90.32% |
| November 30, 2024 | 90.32% |
| October 31, 2024 | 90.32% |
| Date | Value |
|---|---|
| September 30, 2024 | 90.32% |
| August 31, 2024 | 90.32% |
| July 31, 2024 | 90.32% |
| June 30, 2024 | 90.32% |
| May 31, 2024 | 90.32% |
| April 30, 2024 | 90.32% |
| March 31, 2024 | 90.32% |
| February 29, 2024 | 90.32% |
| January 31, 2024 | 89.56% |
| December 31, 2023 | 89.56% |
| November 30, 2023 | 86.84% |
| October 31, 2023 | 85.84% |
| September 30, 2023 | 85.84% |
| August 31, 2023 | 85.84% |
| July 31, 2023 | 85.84% |
| June 30, 2023 | 85.84% |
| May 31, 2023 | 85.84% |
| April 30, 2023 | 85.84% |
| March 31, 2023 | 85.84% |
| February 28, 2023 | 85.84% |
| January 31, 2023 | 85.84% |
| December 31, 2022 | 85.84% |
| November 30, 2022 | 85.69% |
| October 31, 2022 | 85.69% |
| September 30, 2022 | 84.90% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 96.33% |
| Viking Therapeutics, Inc. | 89.26% |
| IDEAYA Biosciences, Inc. | 69.42% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 66.41% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.75 |
| Beta (5Y) | 0.7111 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.05% |
| Historical Sharpe Ratio (5Y) | -0.3373 |
| Historical Sortino (5Y) | -0.7931 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.48% |